GenTrust LLC Buys New Stake in Tenet Healthcare Corporation $THC

GenTrust LLC purchased a new stake in shares of Tenet Healthcare Corporation (NYSE:THC) in the third quarter, Holdings Channel.com reports. The institutional investor purchased 4,406 shares of the company’s stock, valued at approximately $895,000.

Other large investors have also made changes to their positions in the company. William B. Walkup & Associates Inc. acquired a new stake in Tenet Healthcare in the 3rd quarter valued at approximately $32,000. Westside Investment Management Inc. lifted its position in shares of Tenet Healthcare by 100.0% in the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after acquiring an additional 96 shares during the period. Trust Co. of Vermont bought a new stake in shares of Tenet Healthcare during the third quarter valued at approximately $41,000. Canada Pension Plan Investment Board acquired a new position in shares of Tenet Healthcare in the second quarter valued at $35,000. Finally, Caitong International Asset Management Co. Ltd lifted its position in Tenet Healthcare by 2,227.3% in the second quarter. Caitong International Asset Management Co. Ltd now owns 256 shares of the company’s stock worth $45,000 after purchasing an additional 245 shares during the period. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Price Performance

Tenet Healthcare stock opened at $230.90 on Friday. The stock has a market cap of $20.29 billion, a price-to-earnings ratio of 14.91, a P/E/G ratio of 0.96 and a beta of 1.44. Tenet Healthcare Corporation has a 12-month low of $109.82 and a 12-month high of $235.77. The company has a quick ratio of 1.64, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. The business’s 50-day simple moving average is $198.82 and its 200 day simple moving average is $194.95.

Tenet Healthcare (NYSE:THC) last released its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company’s revenue was up 8.9% compared to the same quarter last year. During the same period in the prior year, the company posted $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, research analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Nadja West sold 2,178 shares of the stock in a transaction on Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the transaction, the director owned 28,480 shares of the company’s stock, valued at $5,623,945.60. This represents a 7.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.81% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on THC shares. Barclays upped their price target on Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a research report on Friday. Guggenheim boosted their target price on Tenet Healthcare from $257.00 to $271.00 and gave the stock a “buy” rating in a report on Friday. UBS Group raised their price target on Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a report on Thursday. Jefferies Financial Group boosted their price objective on Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a research note on Thursday. Finally, Royal Bank Of Canada lifted their price target on Tenet Healthcare from $253.00 to $277.00 and gave the company an “outperform” rating in a report on Thursday. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $242.82.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.